pregleda

STEENBLOCK, UMBILICAL CORD STEM CELL THERAPY


Cena:
1.000 din
Stanje: Polovan bez oštećenja
Garancija: Ne
Isporuka: Pošta
CC paket (Pošta)
Lično preuzimanje
Plaćanje: Tekući račun (pre slanja)
PostNet (pre slanja)
Lično
Grad: Novi Sad,
Novi Sad
Prodavac Nije trgovac

zddravko100 (13994)

PREMIUM član
Član je postao Premium jer:
- ima 100 jedinstvenih pozitivnih ocena od kupaca,
- tokom perioda od 6 meseci uplati minimum 20.000 dinara na svoj Limundo račun.

100% pozitivnih ocena

Pozitivne: 33219

  Pošalji poruku

Svi predmeti člana


Kupindo zaštita

Godina izdanja: Ostalo
ISBN: Ostalo
Oblast: Alternativna medicina
Jezik: Engleski
Autor: Strani

TG113) David A. Steenblock, M.S., D.O., is an osteopathic physician known for his work in regenerative medicine and his advocacy for umbilical cord stem cell therapy.
The Book: `Umbilical Cord Stem Cell Therapy`
Steenblock co-authored the book Umbilical Cord Stem Cell Therapy: The Gift of Healing from Healthy Newborns with Anthony G. Payne.
Purpose: The book explores the science and clinical potential of human umbilical-cord stem cells (hUCSCs) as a safer and more potent alternative to embryonic or adult-derived stem cells.
Conditions Addressed: It details the use of these cells for treating `intractable` diseases such as multiple sclerosis (MS), amyotrophic lateral sclerosis (ALS), stroke, cerebral palsy, and degenerative eye disorders.
Clinical Approach and Research
Steenblock Research Institute: Based in San Clemente, California, Steenblock conducts research and offers therapies aimed at neuro-rehabilitation and chronic disease management.
Early Trials: In 2004, Steenblock conducted a pilot study in Mexico involving children with cerebral palsy, reporting improvements in mobility and cognitive function after umbilical cord stem cell transplants.
Cell Potency: His work emphasizes that hUCSCs are `primitive` and highly active, often outperforming the patient`s own (autologous) stem cells, which decrease in number and effectiveness with age.
Medical Context (2026)
FDA Status: While cord blood stem cells are FDA-approved for specific blood and immune disorders (e.g., leukemia), many other applications mentioned in Steenblock`s work remain experimental or are performed in clinical trial settings.
Patient Impact: Patients often seek out Steenblock`s clinic for conditions where conventional treatments have failed, though some critics argue that the field requires more standardized large-scale data.



Predmete ne šaljem pouzećem, jedino nakon uplate. Knjige ne šaljem kao obična tiskovina, jedino kao preporučena tiskovina. Kada je označena besplatna dostava to se odnosi na dostavu kao preporučena tiskovina(do 2 kilograma) ili cc paket(preko 2 kilograma), unutar Srbije. Ostale načine dostave plaća kupac. Ukoliko kupite barem jedan predmet koji ima oznaku „Besplatna dostava”, sve ostale knjige kupljene u istoj narudžbini šalju se u istom paketu bez ikakvih dodatnih troškova poštarine za vas. Šaljem najranije sledeći radni dan pošto legne uplata. Imam puno knjiga i ne mogu da garantujem da su sve na stanju, ponekad se zagube i u tom smislu bih vas zamolio za razumevanje, ako se to desi. U inostranstvo ne šaljem antikvarne knjige. Lično preuzimanje je na mojoj kućnoj adresi (nalazim se u širem centru, u blizini `Puteva Srbije`).

Predmet: 83234929
TG113) David A. Steenblock, M.S., D.O., is an osteopathic physician known for his work in regenerative medicine and his advocacy for umbilical cord stem cell therapy.
The Book: `Umbilical Cord Stem Cell Therapy`
Steenblock co-authored the book Umbilical Cord Stem Cell Therapy: The Gift of Healing from Healthy Newborns with Anthony G. Payne.
Purpose: The book explores the science and clinical potential of human umbilical-cord stem cells (hUCSCs) as a safer and more potent alternative to embryonic or adult-derived stem cells.
Conditions Addressed: It details the use of these cells for treating `intractable` diseases such as multiple sclerosis (MS), amyotrophic lateral sclerosis (ALS), stroke, cerebral palsy, and degenerative eye disorders.
Clinical Approach and Research
Steenblock Research Institute: Based in San Clemente, California, Steenblock conducts research and offers therapies aimed at neuro-rehabilitation and chronic disease management.
Early Trials: In 2004, Steenblock conducted a pilot study in Mexico involving children with cerebral palsy, reporting improvements in mobility and cognitive function after umbilical cord stem cell transplants.
Cell Potency: His work emphasizes that hUCSCs are `primitive` and highly active, often outperforming the patient`s own (autologous) stem cells, which decrease in number and effectiveness with age.
Medical Context (2026)
FDA Status: While cord blood stem cells are FDA-approved for specific blood and immune disorders (e.g., leukemia), many other applications mentioned in Steenblock`s work remain experimental or are performed in clinical trial settings.
Patient Impact: Patients often seek out Steenblock`s clinic for conditions where conventional treatments have failed, though some critics argue that the field requires more standardized large-scale data.



83234929 STEENBLOCK, UMBILICAL CORD STEM CELL THERAPY

LimundoGrad koristi kolačiće u statističke i marketinške svrhe. Nastavkom korišćenja sajta smatramo da ste pristali na upotrebu kolačića. Više informacija.